5 Insightful Analyst Questions From Altria's Q4 Earnings Call

Altria’s fourth quarter results drew a negative market reaction, largely due to a pronounced decline in operating margin despite surpassing sales expectations. Management pointed to increased investments in manufacturing capabilities and ongoing pressure from illicit e-vapor products as key factors impacting profitability. CEO Billy Gifford noted that, while the company achieved meaningful milestones in its smoke-free portfolio, “the proliferation of illicit flavored disposable e-vapor products evading regulatory process… jeopardizes the long-term tobacco harm reduction opportunity.”

Is now the time to buy MO? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Altria’s Q4 Earnings Call

• Matthew Edward Smith (Bank of America): Asked about the scope and timing of import-export benefits and whether cost efficiencies or increased throughput would drive profit improvement. CEO Billy Gifford explained both factors contribute and highlighted Richmond’s manufacturing center as a future hub for international demand.
• Bonnie Lee Herzog (Goldman Sachs): Questioned the relationship between Basic’s promotional strategy and net price realization, as well as implications for EPS guidance. Gifford clarified that Basic’s expansion and import-export initiatives are independent, with Basic targeting stores where consumers face economic pressure.
• Eric Adam Serotta (Morgan Stanley): Inquired about trends in nicotine use among younger adults and the pricing strategy for ON PLUS. Gifford stated there was no notable uptick among young legal-aged consumers and emphasized ON PLUS’s premium positioning and positive consumer feedback.
• Mirza Faham Baig (UBS): Sought clarity on the drivers of elevated controllable costs and the timeline for national ON PLUS distribution. CFO Salvatore Mancuso attributed higher costs to manufacturing investments and confirmed the nationwide rollout would occur in the first half of the year.
• Pallav Mittal (Barclays): Asked about the impact of competitor promotions on pouch pricing and the rationale for the phased ON PLUS launch. Gifford cited significant competitor promotions as the driver of lower category prices and explained the initial three-state launch was due to existing retail relationships.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will be monitoring (1) the pace and consumer adoption of a national ON PLUS launch, (2) progress toward realizing import-export tax efficiencies and related margin stabilization, and (3) regulatory enforcement developments targeting illicit e-vapor products. The trajectory of manufacturing investments and the ability to sustain premium pricing in nicotine pouches will also be critical signposts for Altria’s progress.

Altria currently trades at $65.03, up from $63.13 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.